Skip to main
SNWV
SNWV logo

SNWV Stock Forecast & Price Target

SNWV Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SANUWAVE Health demonstrated impressive financial performance in 2024, achieving a 60% year-over-year sales growth, resulting in revenue of $32.6 million driven by both system sales and consumables. The company also significantly improved its adjusted EBITDA margin, increasing by 28 points to 22%, indicating enhanced operational efficiency. Despite a rise in operating expenses to $6.4 million, primarily due to non-cash stock-based compensation and NASDAQ fees, the overall financial metrics suggest a strong and positive outlook for the company's future.

Bears say

The financial analysis indicates a negative outlook for SANUWAVE Health's stock primarily due to decreased applicator usage in the first quarter, which reflects a typical seasonal patient behavior pattern after the resetting of annual insurance deductibles. Additionally, concerns such as margin compression, competitive headwinds, reduced sales representative productivity, and potential manufacturing setbacks pose significant risks to the company's growth and operational efficiency. These factors collectively point to challenges in maintaining sales momentum and profitability, which could adversely affect SANUWAVE Health's financial performance.

SNWV has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SANUWAVE Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SANUWAVE Health Inc (SNWV) Forecast

Analysts have given SNWV a Buy based on their latest research and market trends.

According to 2 analysts, SNWV has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SANUWAVE Health Inc (SNWV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.